[go: up one dir, main page]

SU1271520A1 - Immunostimulator - Google Patents

Immunostimulator Download PDF

Info

Publication number
SU1271520A1
SU1271520A1 SU813311605A SU3311605A SU1271520A1 SU 1271520 A1 SU1271520 A1 SU 1271520A1 SU 813311605 A SU813311605 A SU 813311605A SU 3311605 A SU3311605 A SU 3311605A SU 1271520 A1 SU1271520 A1 SU 1271520A1
Authority
SU
USSR - Soviet Union
Prior art keywords
vitamin
glucose
folic acid
pentoxyl
immunostimulant
Prior art date
Application number
SU813311605A
Other languages
Russian (ru)
Inventor
Нина Ивановна Иванова
Виктория Васильевна Талько
Николай Иванович Лисяный
Original Assignee
Киевский Научно-Исследовательский Институт Медицинских Проблем Физической Культуры
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киевский Научно-Исследовательский Институт Медицинских Проблем Физической Культуры filed Critical Киевский Научно-Исследовательский Институт Медицинских Проблем Физической Культуры
Priority to SU813311605A priority Critical patent/SU1271520A1/en
Application granted granted Critical
Publication of SU1271520A1 publication Critical patent/SU1271520A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относитс  к медицине . Цель изобретени  - устранение побочного действи  - раздражени  слизистой оболочки желудка за счет введени  в иммуностимул тор фолиевой кислоты, витамина Б глюкозы. Иммуностимул тор содержит, ч: пентоксил 0,05-0,2; фолиева  кислота 0,002-0,01; витамин В 0,05-0,3; глюкоза 0,05-0,3. Фолиева  кислота и витамин повышает активность пентоксила. При этом суточна  доза пентоксила уменьшаетс  в 8-10 раз. Иммуностимул тор примен ют 1 раз в день в течение 3-4 дней. 1 табл.This invention relates to medicine. The purpose of the invention is to eliminate side effects - irritation of the gastric mucosa due to the introduction of glucose, vitamin B, into the immune stimulator. Immunostimulant contains, h: pentoxyl 0.05-0.2; folic acid 0.002-0.01; vitamin b 0.05-0.3; glucose 0.05-0.3. Folic acid and vitamin increases the activity of pentoxyl. In this case, the daily dose of pentoxyl is reduced by a factor of 8-10. The immunostimulant is used once a day for 3-4 days. 1 tab.

Description

tc tc

ел N3ate N3

Claims (1)

Формула изобретенияClaim Иммуностимулятор на основе 5-оксиметил-4-метилурацила, о т л и-*· чающийся тем, что, с целью устранения побочного действия. раздражения слизистой оболочки желудка, он дополнительно содержит фолиевую кислоту, витамин В , глюкозу при следующем соотношении ком понентов, г:An immunostimulant based on 5-hydroxymethyl-4-methyluracil, about t and - * · characterized in that, in order to eliminate side effects. irritation of the gastric mucosa, it additionally contains folic acid, vitamin B, glucose in the following ratio of components, g: 5-0ксиметил-4~метил- урацил ° 0,05-0,25-0xymethyl-4 ~ methyl uracil ° 0.05-0.2 Фолиевая кислота 0,002-0,01Folic Acid 0.002-0.01 Витамин 0,05-0,3Vitamin 0.05-0.3 Глюкоза 0,05-0,3Glucose 0.05-0.3 ВНИИПИ Заказ 6271 /7__Тираж 660 ____ПодписноеVNIIIPI Order 6271 / 7__ Circulation 660 ____ Subscription Произв.-полигр. пр-тие, г. Ужгород, ул. Проектная, 4Custom polygr. ave, city of Uzhhorod, st. Project, 4
SU813311605A 1981-06-29 1981-06-29 Immunostimulator SU1271520A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU813311605A SU1271520A1 (en) 1981-06-29 1981-06-29 Immunostimulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU813311605A SU1271520A1 (en) 1981-06-29 1981-06-29 Immunostimulator

Publications (1)

Publication Number Publication Date
SU1271520A1 true SU1271520A1 (en) 1986-11-23

Family

ID=20966967

Family Applications (1)

Application Number Title Priority Date Filing Date
SU813311605A SU1271520A1 (en) 1981-06-29 1981-06-29 Immunostimulator

Country Status (1)

Country Link
SU (1) SU1271520A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008960A1 (en) * 1995-09-05 1997-03-13 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Antistress agents for aquatic animals
RU2167660C2 (en) * 1998-11-16 2001-05-27 Тверская медакадемия Method of correction of immunological status of patients with lung cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Машковский М.Д. Лекарственные средства. -М.: Медицина, 1977, с. 517. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008960A1 (en) * 1995-09-05 1997-03-13 Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh Antistress agents for aquatic animals
RU2167660C2 (en) * 1998-11-16 2001-05-27 Тверская медакадемия Method of correction of immunological status of patients with lung cancer

Similar Documents

Publication Publication Date Title
SE425715B (en) PROCEDURE FOR THE PREPARATION OF AN AMINO ACID PREPARATION, PROVIDED FOR ADMINISTRATION TO HUMAN PATIENTS WITH Liver disease
EP0567201A3 (en) Vehicle for oral administration of acid labile pharmaceuticals.
ES8307210A1 (en) Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them.
Malkasian Jr et al. Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma
ES8102141A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
GB1503675A (en) Compositions based on pyrimidine derivatives and their use in the treatment of viral infections
FR2367750A1 (en) ACID
SU1271520A1 (en) Immunostimulator
GB1334327A (en) Compositions for and method of combating virus infections
NO169487C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,3-DIHYDROBENZOFURAN-5-SULPHONAMIDES
SE8500996D0 (en) METHOD OF TREATMENT
FR2407928A1 (en) QUINAZOLINE DERIVATIVES FOR USE AS ANTIHYPERTENSE MEDICINES AND PROCESS FOR THEIR PREPARATION
JPS54138126A (en) Remedy for diabetes
ES8802612A1 (en) Benzisoselenazolonyl derivatives, process for their preparation and pharmaceutical compositions containing them.
RU93021200A (en) METHOD FOR TREATING ZINC DEFICIENCY CONDITIONS
EP0093497A3 (en) Anthelmintic treatment
GB1463505A (en) Pharmaceutical compositions
SU459228A1 (en) Medicine
GB1437138A (en) Method of increasing sexual potency
SU606242A1 (en) "dimotziphon" anti-leprose preparation
GB1395929A (en) Thioureas
GB1342643A (en) Thioacetanilide derivatives
GB1176157A (en) Orotic Acid Salt
Cayer et al. The Effects of Choline and Methionine on Phospholipide Formation in Patients with Liver Disease as Measured by Radioactive Phosphorus
IE40758B1 (en) New basic enol ethers,their salts,process for their preparation and pharmaceutical preparations containing the same